as on December 13, 2025 at 2:29 am IST
Day's Low
Day's High
1.20%
Downside
2.26%
Upside
52 Week's Low
52 Week's High
43.27%
Downside
20.82%
Upside
Check Mirum Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.4B
EPS (TTM)
-0.3786
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-18.35
Industry PE ratio
8.214070796460177
PEG Ratio
0EBITDA
-17.6M
Revenue (TTM)
471.8M
Profit Margin
-8.78%
Return On Equity TTM
-15.81%
Track how Mirum Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Mirum Pharmaceuticals Inc in the last 5 years
Lowest (-69.86x)
September 30, 2025
Today (-18.35x)
December 13, 2025
Industry (8.21x)
December 13, 2025
Highest (-2.45x)
December 31, 2021
Today’s Price to Earnings Ratio: -18.35x
Compare market cap, revenue, PE, and other key metrics of Mirum Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.4B | 155.4% | -18.35 | -8.78% | |
| BUY | $42.0B | 393.88% | -16.34 | -264.83% | |
| BUY | $54.5B | 206.63% | 1422.86 | 1.36% | |
| BUY | $114.3B | 101.65% | 31.25 | 31.35% | |
| BUY | $79.2B | 54.51% | 17.42 | 32.13% |
The Mirum Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Mirum Pharmaceuticals Inc investment value today
Current value as on today
₹1,59,943
Returns
₹59,943
(+59.94%)
Returns from Mirum Pharmaceuticals Inc Stock
₹53,181 (+53.18%)
Dollar Returns*
₹6,762 (+6.76%)
Based on 17 analysts
94.12%
Buy
5.88%
Hold
0.00%
Sell
Based on 17 analysts, 94.12% of analysts recommend a 'BUY' rating for Mirum Pharmaceuticals Inc. Average target price of $98
Get share price movements and forecasts by analysts on Mirum Pharmaceuticals Inc.
What analysts predicted
33.66%UPSIDE
Target Price
$98
Current Price
$65.01
Analyzed by
17 Analysts
Target
$98.00
Mirum Pharmaceuticals Inc target price $98, a slight upside of 33.66% compared to current price of $65.01. According to 17 analysts rating.
Search interest for Mirum Pharmaceuticals Inc Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:100% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 7 quarters, 69.22M → 133.00M (in $), with an average increase of 10.3% per quarter
Price Rise
![]()
In the last 3 years, MIRM stock has moved up by 260.7%
Profit Spike
![]()
Netprofit is up for the last 4 quarters, -23.79M → 2.90M (in $), with an average increase of 171.4% per quarter
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 175.0% return, outperforming this stock by 121.8%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 885.5% return, outperforming this stock by 624.8%
| Organisation | Mirum Pharmaceuticals Inc |
| Headquarters | 950 Tower Lane, Foster City, CA, United States, 94404 |
| Industry | Health Technology |
| CEO | Mr. Christopher Peetz |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Douglas T. Sheehy J.D. | Chief Legal Officer |
Mr. Christopher Peetz | CEO & Director |
Mr. Eric H. Bjerkholt M.B.A., M.S. | Chief Financial Officer |
Dr. Joanne M. J. Quan M.D. | Chief Medical Officer |
Mr. Paul K. Ross | Chief Compliance Officer |
Ms. Lara Longpre MBA, MSC | Chief Development Officer |
Ms. Vinita P. Kumar | Senior Vice President of Quality |
Mr. Peter Radovich M.B.A., Ph.D. | COO & President |
Dr. Jean-Luc Girardet Ph.D. | Chief Technical Officer |
Mr. Andrew McKibben | Senior Vice President, Strategic Finance & Investor Relations |
Mirum Pharmaceuticals Inc share price today is $65.01 as on at the close of the market. Mirum Pharmaceuticals Inc share today touched a day high of $66.48 and a low of $64.23.
Mirum Pharmaceuticals Inc share touched a 52 week high of $78.54 on and a 52 week low of $36.88 on . Mirum Pharmaceuticals Inc stock price today i.e. is closed at $65.01,which is 17.23% down from its 52 week high and 76.27% up from its 52 week low.
Mirum Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Mirum Pharmaceuticals Inc (MIRM) shares with as little as ₹90.544 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.44 in Mirum Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Mirum Pharmaceuticals Inc share’s latest price of $65.01 as on December 13, 2025 at 2:29 am IST, you will get 0.1538 shares of Mirum Pharmaceuticals Inc. Learn more about
fractional shares .
Mirum Pharmaceuticals Inc stock has given 155.4% share price returns and 21.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?